Shanghai Hile Bio-Technology Co., Ltd. (SHSE: 603718)
Health Care · Pharmaceuticals · CN
CN¥3.06
-0.97% today · -55.5% 1Y
Shanghai Hile Bio-Technology Co., Ltd. (SHSE: 603718) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $296.48M and employs 340 people.
Over the last twelve months the share price has lost 55.5%, trading between 2.57 and 7.38.
Tweenvest scores Shanghai Hile Bio-Technology Co., Ltd. across four factors: quality 73/100, value 58/100, growth 0/100. Its strongest factor is quality.
603718 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $296.48M
- Revenue (TTM)
- $31.50M
- P/E
- —
- EPS
- -0.49
- Dividend yield
- —
- Beta (5Y)
- 0.18
- 52-week high
- CN¥7.38
- 52-week low
- CN¥2.57
- Avg volume (3M)
- —
- Shares outstanding
- 648.98M
- Employees
- 340
- Next earnings
- —
About Shanghai Hile Bio-Technology Co., Ltd.
Shanghai Hile Bio-Technology Co., Ltd. develops, manufactures, and sells in vitro diagnostic reagents and oral tissue repair and regeneration materials in China. It operates through two segments: In Vitro Diagnostic Reagents and Oral Tissue Repair and Regeneration Materials. The In Vitro Diagnostic Reagents segment offers biochemical diagnostic reagents, immuno-latex reagents, immune turbidimetry reagents, latex enhanced immune turbidimetry reagents, enzyme-linked immunosorbent products, and related diagnostic kits, including matrix metalloproteinase 3, IV collagen, adiponectin, creatine kinase isoenzyme, hepatic bile acid, cardiac troponin I, heparin binding protein, hemoglobin A1C, lipoprotein phospholipase A2, heart fatty acid binding protein, ferritin, sialoglycoside antigen, and procalcitonin kits. The Oral Tissue Repair and Regeneration Materials segment provides oral bone repair materials, implant systems, natural bone repair materials, oral restorative films, collagen-based bone repair matrices, and soft tissue repair matrices, primarily for dental implantation and maxillofacial bone defect repair. The company was founded in 1981 and is headquartered in Shanghai, China.
- ISIN
- CNE1000022T4
- Founded
- 1981
- Listed since
- May 15, 2015
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| EI- Nile Co. for Pharmaceuticals and Chemical IndustriesCASE: NIPH | $301.23M | EGP315.50 | -4.69% |
| Biofarm S.A.BVB: BIO | $299.92M | RON— | — |
| Zhejiang Benli Technology Co., Ltd.SZSE: 301065 | $297.77M | CN¥19.88 | -0.90% |
| Bukwang Pharmaceutical Co., Ltd.KOSE: A003000 | $297.60M | ₩4,055.00 | -1.10% |
| Aurora Cannabis Inc.TSX: ACB | $295.82M | CA$6.42 | +1.58% |
| Fuji Pharma Co., Ltd.TSE: 4554 | $293.63M | ¥1,780.00 | +3.49% |
| EyePoint, Inc.NasdaqGM: EYPT | $293.12M | $3.30 | -3.09% |
| BioAge Labs, Inc.NasdaqGS: BIOA | $290.99M | $5.94 | -6.31% |
Figures last refreshed Oct 11, 2026.